Invention Grant
- Patent Title: Oral cholestyramine formulation and use thereof
-
Application No.: US15988317Application Date: 2018-05-24
-
Publication No.: US10758563B2Publication Date: 2020-09-01
- Inventor: Per-Göran Gillberg , Nils Ove Gustafsson , Nils-Olof Lindberg , Jessica Elversson
- Applicant: Albireo AB
- Applicant Address: SE Gothenburg
- Assignee: Albireo AB
- Current Assignee: Albireo AB
- Current Assignee Address: SE Gothenburg
- Agency: Fish & Richardson P.C.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@1974b48b
- Main IPC: A61K31/745
- IPC: A61K31/745 ; A61K9/16 ; A61K45/06 ; A61K9/50 ; A61K31/554 ; A61K31/785 ; A61K9/20
Abstract:
The invention relates to an oral formulation for targeted delivery of cholestyramine to the colon, comprising a plurality of cholestyramine pellets that are coated with a colon release coating. The invention also relates to the use of this formulation in the treatment of bile acid malabsorption.
Public/Granted literature
- US20180360871A1 ORAL CHOLESTYRAMINE FORMULATION AND USE THEREOF Public/Granted day:2018-12-20
Information query
